Research on Risk Identification and Control of Medicine Supply Chain

Hong-qi Wang (), Xiang Gao and Shan-shan Wang ()
Additional contact information
Hong-qi Wang: Harbin University of Science &Technology
Xiang Gao: Harbin University of Science &Technology
Shan-shan Wang: Harbin University of Science &Technology

Chapter Chapter 37 in Proceedings of 2012 3rd International Asia Conference on Industrial Engineering and Management Innovation (IEMI2012), 2013, pp 367-377 from Springer

Abstract: Abstract With the deepening of medical and health system reform in China, it is necessary to strengthen risk management of medicine supply chain so as to improve the medicine distribution level and cut down the medicine price, and increasingly great concern has been aroused by government, pharmaceutical industry and society. In light of the complexity and uncertainty of medicine market, this paper makes analysis on the composition of medicine supply chain and its risks, constructs a risk identification hierarchy structure of medicine supply chain, and then designs the risk control model. This paper aims at providing support for medicine supply chain to reduce the risks and increase the operational level.

Keywords: Medicine supply chain; Risk identification; Risk control (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-33012-4_37

Ordering information: This item can be ordered from
http://www.springer.com/9783642330124

DOI: 10.1007/978-3-642-33012-4_37

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().